Dark Forest Capital Management’s Edwards Lifesciences EW Stock Holding History

Dark Forest Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,938	Closed	-$677K	–	900
2025 Q4	$677K	Sell	7,938 -20,472	-72%	-$1.68M	0.03%	750
2025 Q3	$2.21M	Buy	28,410 +13,039	+85%	+$1.02M	0.08%	428
2025 Q2	$1.2M	Buy	+15,371	New	+$1.15M	0.05%	677
2025 Q1	–	Sell	-10,404	Closed	-$770K	–	1291
2024 Q4	$770K	Buy	10,404 +7,196	+224%	+$504K	0.11%	252
2024 Q3	$212K	Buy	+3,208	New	+$233K	0.03%	849
2024 Q2	–	Sell	-2,639	Closed	-$252K	–	723
2024 Q1	$252K	Buy	+2,639	New	+$222K	0.04%	527
2023 Q4	–	Sell	-25,700	Closed	-$1.78M	–	679
2023 Q3	$1.78M	Buy	+25,700	New	+$2.07M	0.14%	174
2022 Q4	–	Sell	-121	Closed	-$10K	–	1247
2022 Q3	$10K	Buy	121 +118	+3,933%	+$11.4K	﹤0.01%	738
2022 Q2	$0	Sell	3 -930	-100%	-$96.3K	﹤0.01%	1030
2022 Q1	$109K	Buy	933 +718	+334%	+$80.5K	0.03%	479
2021 Q4	$28K	Sell	215 -435	-67%	-$50.7K	0.01%	570
2021 Q3	$74K	Buy	+650	New	+$74.2K	0.03%	467

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Dark Forest Capital Management's EW Position: Q1 2026 in Review

Dark Forest Capital Management sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 7,938 shares — an estimated $677K sold.

Dark Forest Capital Management first reported a position in EW in Q3 2021 and held it in 12 quarters. The position peaked at $2.21M in Q3 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Dark Forest Capital Management reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
Dark Forest Capital Management sold 7,938 Edwards Lifesciences shares in Q1 2026, an estimated $677K.
Dark Forest Capital Management first reported a position in Edwards Lifesciences in Q3 2021 and held it in 12 quarters.
Dark Forest Capital Management's Edwards Lifesciences position peaked at $2.21M in Q3 2025.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.